Koers BrainsWay Ltd. TEL AVIV STOCK EXCHANGE
Aandelen
BWAY
IL0011007189
Geavanceerde medische apparatuur & technologie
Omzet 2024 * | 37,78 mln. 143 mln. 35,46 mln. | Omzet 2025 * | 44,04 mln. 167 mln. 41,33 mln. | Marktkapitalisatie | 84,51 mln. 321 mln. 79,32 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | - 0 0 | Nettowinst (verlies) 2025 * | 2 mln. 7,59 mln. 1,88 mln. | EV/omzet 2024 * | 2,24 x |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 1,92 x |
K/w-verhouding 2024 * |
-
| K/w-verhouding 2025 * |
-
| Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 80,14% |
Recentste transcriptie over BrainsWay Ltd.
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Hadar Levy
CEO | Chief Executive Officer | 52 | 14-09-14 |
Yiftach Roth
FOU | Founder | 54 | 01-05-06 |
David Zacut
FOU | Founder | 72 | 07-11-06 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Josef Ben Shalom
BRD | Director/Board Member | 68 | 01-12-18 |
Karen Sarid
BRD | Director/Board Member | 73 | 03-12-17 |
Amiram Boehm
CHM | Chairman | 52 | 12-01-23 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+2,29% | 209 mld. | |
+2,39% | 177 mld. | |
+10,30% | 133 mld. | |
+17,12% | 99,89 mld. | |
-2,70% | 61,83 mld. | |
+13,32% | 52,51 mld. | |
-6,21% | 45,54 mld. | |
-3,72% | 39,43 mld. | |
+9,75% | 38,87 mld. |